Specialised - Bleeding Disorders
The products to be included in the procurement exercise are: Recombinant factor VIIa, PDFVIII containing vWF concentrate, PDFIX concentrate, PD pure vWF concentrate, PD Factor VIII Inhibitor Bypassing Fraction (FEIBA), PD Factor XIII concentrate, PD Protein C Concentrate, PD Fibrinogen concentrate, Fresh Frozen Plasma, PD FX concentrate, Recombinant Porcine Factor VIII concentrate, Prothrombin Complex Concentrate, Emicizumab (humanised bispecific antibody).
Buyer
NHS ENGLAND
Value
£92,500,000
Published
31 Jan 2018
Closes
31 Jan 2018
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33141530
Blood coagulants
Lots
Lot default Specialised - Bleeding Disorders
£92,500,000
The products to be included in the procurement exercise are: Recombinant factor VIIa, PDFVIII containing vWF concentrate, PDFIX concentrate, PD pure vWF concentrate, PD Factor VIII Inhibitor Bypassing Fraction (FEIBA), PD Factor XIII concentrate, PD Protein C Concentrate, PD Fibrinogen concentrate, Fresh Frozen Plasma, PD FX concentrate, Recombinant Porcine...
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkFuture opportunity notice on Contracts Finder
31 Jan 2018
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.